日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model

XPO1抑制剂联合伊立替康在临床前结直肠癌模型中的疗效

Lentz, Robert W; Dominguez, Adrian T A; Balmaceda, Nicole Baranda; Arcaroli, John J; Bagby, Stacey M; Binns, Cameron A; Smoots, Stephen G; Jackson, Marilyn M; Macbeth, Morgan; Holmstoen, Tessa; Banerjee, Tapahsama; Whitty, Phaedra A; Yi, S Stephen; Lieu, Christopher H; Messersmith, Wells A; Pitts, Todd M

Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer.

通过抑制 BCL-2 增强阿霉素在 p53 野生型和突变型三阴性乳腺癌中的活性

Schreiber Anna R, Smoots Stephen G, Jackson Marilyn M, Bagby Stacey M, Dus Evan D, Dominguez Adrian T A, Binns Cameron A, Pitts Todd M, Diamond Jennifer R